2m 2m 2m 2m 2m 2m 2m
SIONNA THER (SION)
NASDAQ
$42.10+$3.27 (+8.42%)
Price as of Jun 23, 2026 5:19 PM EDT- $1.8BMarket Cap
- 175.39%1-Year Change
- BiotechnologyIndustry
SIONNA THER (SION)
$42.10+$3.27 (+8.42%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | N/A N/A | |
Cost of Revenue | N/A N/A | |
Gross Profit | 0 N/A | |
Sales and Marketing Expense | N/A N/A | |
Research and Development Expense | -60.3M N/A | |
Depreciation and Amortization Expense | 647,000 N/A | |
Total Operating Expenses | 89.0M N/A | |
Operating Profit | -89.0M N/A | |
Interest Income | 13.3M N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 13.3M N/A | |
Total Nonoperating Income and Expense | 13.7M N/A | |
Income before Taxes | -89.0M N/A | |
Income Taxes | 0 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -75.3M N/A | |
Net Income from Continuing Operations Applicable to Common | -75.3M N/A | |
Basic EPS and Net Income | -1.88 N/A | |
Diluted EPS and Net Income | -1.88 N/A | |
Basic Weighted Average Shares | 40.0M N/A | |
Diluted Weighted Average Shares | 40.0M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 58.5M N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 58.5M N/A | |
Total Current Assets | 241.4M N/A | |
Accumulated Depreciation | 2.1M N/A | |
Property and Plant and Equipment and Net | 2.2M N/A | |
Total Long-Term Assets | 0 N/A | |
Total Assets | 326.0M N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | N/A N/A | |
Total Current Liabilities | 11.7M N/A | |
Total Long-Term Debt | N/A N/A | |
Total Long-Term Liabilities | 7.4M N/A | |
Total Liabilities | 19.1M N/A | |
Retained Earnings | -256.4M N/A | |
Total Stockholders Equity | 306.8M N/A | |
Total Shares Outstanding | 44.7M N/A | |
Cash Flow | ||
Cash from Operating Activities | -66.3M N/A | |
Capital Expenditures | 377,000 N/A | |
Cash from Investing Activities | -118.7M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 205.7M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow